Cargando…

Polycystins, mechanotransduction and cancer development

Detalles Bibliográficos
Autores principales:	Papavassiliou, Kostas A., Gargalionis, Antonios N., Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077297/ https://www.ncbi.nlm.nih.gov/pubmed/35366054 http://dx.doi.org/10.1111/jcmm.17298

Ejemplares similares

Polycystins and mechanotransduction in bone
por: Gargalionis, Antonios N., et al.
Publicado: (2017)

Polycystins and Mechanotransduction in Human Disease
por: Gargalionis, Antonios N., et al.
Publicado: (2019)

Polycystins in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2018)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro
por: Zoi, Ilianna, et al.
Publicado: (2022)

Polycystin‐1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines
por: Papavassiliou, Kostas A., et al.
Publicado: (2019)

Polycystin‐1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model
por: Katsianou, Maira, et al.
Publicado: (2021)

Targeting STAT3 Signaling Pathway in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2021)

Polycystin‐1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model
por: Katsianou, Maria A., et al.
Publicado: (2022)

Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

mTOR Signaling Components in Tumor Mechanobiology
por: Gargalionis, Antonios N., et al.
Publicado: (2022)

Mechanosignalling in tumour progression
por: Gargalionis, Antonios N., et al.
Publicado: (2017)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks
por: Stravopodis, Dimitrios J., et al.
Publicado: (2023)

G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2?
por: Kassi, Eva N., et al.
Publicado: (2020)

Malignant circuits: Novel therapeutic opportunities in neuro‐oncology
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?
por: Kassi, Eva N., et al.
Publicado: (2020)

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
por: Piperi, Christina, et al.
Publicado: (2019)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
por: Karamouzis, Michalis V., et al.
Publicado: (2007)

Polycystin-2 Is Required for Chondrocyte Mechanotransduction and Traffics to the Primary Cilium in Response to Mechanical Stimulation
por: Thompson, Clare L., et al.
Publicado: (2021)

Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severity
por: Varela, Aimilia, et al.
Publicado: (2015)

Solid Cancers and Rheumatoid Arthritis
por: Kalliolias, George D., et al.
Publicado: (2023)

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
por: Markouli, Mariam, et al.
Publicado: (2022)

Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
por: Markouli, Mariam, et al.
Publicado: (2021)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Vitamin D affects glucocorticoid action in target cells
por: Kassi, Eva, et al.
Publicado: (2016)

The ion channel function of polycystin‐1 in the polycystin‐1/polycystin‐2 complex
por: Wang, Zhifei, et al.
Publicado: (2019)

The glucocorticoid receptor signalling in breast cancer
por: Moutsatsou, Paraskevi, et al.
Publicado: (2008)

A set of sum rules for anomalous gauge boson couplings
por: Papavassiliou, Joannis, et al.
Publicado: (1998)

Probing the $WW \gamma$ vertex at hadron colliders
por: Papavassiliou, Joannis, et al.
Publicado: (1999)

Complexity in cancer biology: is systems biology the answer?
por: Koutsogiannouli, Evangelia, et al.
Publicado: (2013)

A polycystin-centric view of cyst formation and disease: the polycystins revisited
por: Ong, Albert CM, et al.
Publicado: (2015)

Could glucose be a proaging factor?
por: Kassi, Eva, et al.
Publicado: (2008)

Glucose can promote a glucocorticoid resistance state
por: Kassi, Eva, et al.
Publicado: (2012)

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
por: Koustas, Evangelos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08seicbikkaa1pap2atvag8mlf